Literature DB >> 17724804

Perimuscular connective tissue contains more and larger lymphatic vessels than the shallower layers in human gallbladders.

Masayuki Nagahashi1, Yoshio Shirai, Toshifumi Wakai, Jun Sakata, Yoichi Ajioka, Katsuyoshi Hatakeyama.   

Abstract

AIM: To clarify whether perimuscular connective tissue contains more lymphatic vessels than the shallower layers in human gallbladders.
METHODS: Lymphatic vessels were stained immunohistochemically with monoclonal antibody D2-40, which is a specific marker of lymphatic endothelium, in representative sections of 12 normal human gallbladders obtained at the time of resection for colorectal carcinoma liver metastases. In individual gallbladder specimens, nine high-power (x 200) fields with the highest lymphatic vessel density (LVD), termed "hot spots", were identified for each layer (mucosa, muscle layer, and perimuscular connective tissue). In individual hot spots, the LVD and relative lymphatic vessel area (LVA) were measured microscopically using a computer-aided image analysis system. The mean LVD and LVA values for the nine hot spots in each layer were used for statistical analyses.
RESULTS: In the mucosa, muscle layer, and perimuscular connective tissue, the LVD was 16.1 +/- 9.2, 35.4 +/- 15.7, and 65.5 +/- 12.2, respectively, and the LVA was 0.4 +/- 0.4, 2.1 +/- 1.1, and 9.4 +/- 2.6, respectively. Thus, both the LVD and LVA differed significantly (P < 0.001 and P < 0.001, respectively; Kruskal-Wallis test) among the individual layers of the wall of the gallbladder, with the highest LVD and LVA values in the perimuscular connective tissue. Most (98 of 108) of the hot spots within the perimuscular connective tissue were located within 500 mum of the lower border of the muscle layer.
CONCLUSION: The perimuscular connective tissue contains more and larger lymphatic vessels than the shallower layers in the human gallbladder. This observation partly explains why the incidence of lymph node metastasis is high in T2 (tumor invading the perimuscular connective tissue) or more advanced gallbladder carcinoma.

Entities:  

Mesh:

Year:  2007        PMID: 17724804      PMCID: PMC4611581          DOI: 10.3748/wjg.v13.i33.4480

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors.

Authors:  Harriette J Kahn; Alexander Marks
Journal:  Lab Invest       Date:  2002-09       Impact factor: 5.662

2.  Carcinoma of the gallbladder: a study of its modes of spread.

Authors:  R B FAHIM; J R McDONALD; J C RICHARDS; D O FERRIS
Journal:  Ann Surg       Date:  1962-07       Impact factor: 12.969

3.  Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations.

Authors:  Alessandro Franchi; Oreste Gallo; Daniela Massi; Gianna Baroni; Marco Santucci
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

4.  Observation of lymphatic vessels in orbital fat of patients with inflammatory conditions: a form fruste of lymphangiogenesis?

Authors:  F Fogt; R L Zimmerman; T Daly; R E Gausas
Journal:  Int J Mol Med       Date:  2004-05       Impact factor: 4.101

Review 5.  Carcinoma of the gallbladder.

Authors:  Sanjeev Misra; Arun Chaturvedi; Naresh C Misra; Indra D Sharma
Journal:  Lancet Oncol       Date:  2003-03       Impact factor: 41.316

6.  [Lymphatic and vascular systems of the gallbladder--with special reference to carcinoma of the gallbladder].

Authors:  M Kambayashi
Journal:  Hokkaido Igaku Zasshi       Date:  1989-09

7.  Lymphatic vessel density is significantly increased in melanoma.

Authors:  T A Giorgadze; P J Zhang; T Pasha; P S Coogan; G Acs; D E Elder; X Xu
Journal:  J Cutan Pathol       Date:  2004-11       Impact factor: 1.587

Review 8.  Long-term results after resection for gallbladder cancer. Implications for staging and management.

Authors:  D L Bartlett; Y Fong; J G Fortner; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

9.  Lymph node spread from carcinoma of the gallbladder.

Authors:  K Tsukada; I Kurosaki; K Uchida; Y Shirai; Y Oohashi; N Yokoyama; H Watanabe; K Hatakeyama
Journal:  Cancer       Date:  1997-08-15       Impact factor: 6.860

10.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Authors:  M Skobe; T Hawighorst; D G Jackson; R Prevo; L Janes; P Velasco; L Riccardi; K Alitalo; K Claffey; M Detmar
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

View more
  8 in total

1.  Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.

Authors:  Junichi Shindoh; Xabier de Aretxabala; Thomas A Aloia; Juan Carlos Roa; Ivan Roa; Giuseppe Zimmitti; Milind Javle; Claudius Conrad; Dipen M Maru; Taku Aoki; Luca Vigano; Dario Ribero; Norihiro Kokudo; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

2.  Gastrointestinal lymphatics in health and disease.

Authors:  J S Alexander; Vijay C Ganta; P A Jordan; Marlys H Witte
Journal:  Pathophysiology       Date:  2010-09

3.  ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.

Authors:  Akimitsu Yamada; Masayuki Nagahashi; Tomoyoshi Aoyagi; Wei-Ching Huang; Santiago Lima; Nitai C Hait; Aparna Maiti; Kumiko Kida; Krista P Terracina; Hiroshi Miyazaki; Takashi Ishikawa; Itaru Endo; Michael R Waters; Qianya Qi; Li Yan; Sheldon Milstien; Sarah Spiegel; Kazuaki Takabe
Journal:  Mol Cancer Res       Date:  2018-03-09       Impact factor: 5.852

Review 4.  Lymphangiogenesis: a new player in cancer progression.

Authors:  Masayuki Nagahashi; Subramaniam Ramachandran; Omar M Rashid; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

5.  Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.

Authors:  Masayuki Nagahashi; Subramaniam Ramachandran; Eugene Y Kim; Jeremy C Allegood; Omar M Rashid; Akimitsu Yamada; Renping Zhao; Sheldon Milstien; Huiping Zhou; Sarah Spiegel; Kazuaki Takabe
Journal:  Cancer Res       Date:  2012-02-01       Impact factor: 12.701

Review 6.  Bevacizumab and breast cancer: what does the future hold?

Authors:  Christina E Stevenson; Masayuki Nagahashi; Subramaniam Ramachandran; Akimitsu Yamada; Harry D Bear; Kazuaki Takabe
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

Review 7.  Early-stage T1b adenocarcinoma arising in the remnant cystic duct after laparoscopic cholecystectomy: a case report and literature review.

Authors:  Pankaj Prasoon; Yuki Hirose; Jun Sakata; Kizuki Yuza; Kazuki Moro; Koji Toge; Kohei Miura; Masayuki Nagahashi; Takashi Kobayashi; Kouei Nihei; Atsuo Nakamura; Toshifumi Wakai
Journal:  BMC Surg       Date:  2019-11-29       Impact factor: 2.102

8.  Prognostic impact of tumor location in resected gallbladder cancer: A national cohort analysis.

Authors:  Kelly Lafaro; Andrew M Blakely; Laleh G Melstrom; Susanne G Warner; Byrne Lee; Gagandeep Singh; Yuman Fong; Mustafa Raoof
Journal:  J Surg Oncol       Date:  2020-07-11       Impact factor: 2.885

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.